Literature DB >> 16312130

Adhesion molecules in human dendritic cells.

José Luis Rodríguez-Fernández1, Angel L Corbí.   

Abstract

Dendritic cells are bone marrow-derived professional antigen-presenting cells that link innate and adaptive immunity, and they are essentially involved in the initiation of primary immune responses and in the establishment of peripheral tolerance. The existence of distinct functional states and subsets of dendritic cells is critical for the generation of pathogen-specific immune responses without the risk of autoimmunity or chronic inflammation. To fulfil their effector tasks in tissues and lymph nodes, dendritic cells must engage in multiple adhesive and migratory events. The molecular dissection of these adhesive interactions may provide new potential therapeutic targets to modulate immune responses and to improve current dendritic cell-based therapeutic cancer vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16312130

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  10 in total

1.  Immunological synapse formation inhibits, via NF-kappaB and FOXO1, the apoptosis of dendritic cells.

Authors:  Lorena Riol-Blanco; Cristina Delgado-Martín; Noelia Sánchez-Sánchez; Luis M Alonso-C; María Dolores Gutiérrez-López; Gloria Martínez Del Hoyo; Joaquín Navarro; Francisco Sánchez-Madrid; Carlos Cabañas; Paloma Sánchez-Mateos; José Luis Rodríguez-Fernández
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606

Review 2.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

3.  Effects of lamivudine on the function of dendritic cells derived from patients with chronic hepatitis B virus infection.

Authors:  Peng-Yuan Zheng; Dong-Yun Zhang; Gao-Feng Lu; Ping-Chang Yang; Yuan-Ming Qi; Bai-Sheng Wang
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

4.  Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B.

Authors:  Gao-Feng Lu; Fu-Ai Tang; Peng-Yuan Zheng; Ping-Chang Yang; Yuan-Ming Qi
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 5.  Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?

Authors:  Mohit Sehgal; Zafar K Khan; Andrew H Talal; Pooja Jain
Journal:  Virology (Auckl)       Date:  2013-02-11

6.  Effects of disodium cantharidinate on dendritic cells of patients with bladder carcinoma.

Authors:  Guang-Hui Zang; Rui Li; Rong-Sheng Zhou; Lin Hao; Hou-Guang He; Wen-Da Zhang; Yang Dong; Cong-Hui Han
Journal:  Oncol Lett       Date:  2017-12-12       Impact factor: 2.967

7.  Soluble CD83 Regulates Dendritic Cell-T Cell Immunological Synapse Formation by Disrupting Rab1a-Mediated F-Actin Rearrangement.

Authors:  Wei Lin; Shuping Zhou; Meng Feng; Yong Yu; Qinghong Su; Xiaofan Li
Journal:  Front Cell Dev Biol       Date:  2021-01-22

8.  Down regulation of genes involved in T cell polarity and motility during the induction of heart allograft tolerance by allochimeric MHC I.

Authors:  Wojciech Lisik; Neelam Tejpal; Yongquan Gong; T Spencer Skelton; Malathesh Ganachari; Eric G Bremer; Malgorzata Kloc; Rafik M Ghobrial
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

9.  Genetic deficiency of Itgb2 or ItgaL prevents autoimmune diabetes through distinctly different mechanisms in NOD/LtJ mice.

Authors:  John D Glawe; D Ross Patrick; Meng Huang; Christopher D Sharp; Shayne C Barlow; Christopher G Kevil
Journal:  Diabetes       Date:  2009-02-17       Impact factor: 9.461

10.  A-kinase anchoring in dendritic cells is required for antigen presentation.

Authors:  Robynn V Schillace; Casey L Miller; Neal Pisenti; Jeff E Grotzke; Gwendolyn M Swarbrick; David M Lewinsohn; Daniel W Carr
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.